These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 790087)
21. [Use of diazoxide in the studies of the effect of glucagon on the blood serum levels of glucose, free fatty acids and triglycerides in rabbits]. Nowak KW; Nogowski L Pol Arch Weter; 1987; 27(4):99-107. PubMed ID: 3334161 [TBL] [Abstract][Full Text] [Related]
22. Glucagon infusion, plasma FFA and triglycerides, blood sugar, and liver lipids in birds. Grande F; Prigge WF Am J Physiol; 1970 May; 218(5):1406-11. PubMed ID: 5438269 [No Abstract] [Full Text] [Related]
24. Type V hyperlipoproteinaemia. Metabolic changes in hyperlipaemic and previously hyperlipaemic ("susceptible") male patients. Jacobsen BB Atherosclerosis; 1973; 17(3):471-81. PubMed ID: 4577010 [No Abstract] [Full Text] [Related]
25. Study of serum insulin in atherosclerotic patients with endogenous hypertriglyceridemia (type 3 and IV hyperlipoproteinemia). Kuo PT; Feng LY Metabolism; 1970 May; 19(5):372-80. PubMed ID: 5442617 [No Abstract] [Full Text] [Related]
26. Effects of oxandrolone on plasma triglycerides and postheparin lipolytic activity in patients with types 3, IV, and V familial hyperlipoproteinemia. Glueck CJ Metabolism; 1971 Jul; 20(7):691-702. PubMed ID: 5090133 [No Abstract] [Full Text] [Related]
27. Diurnal patterns of blood sugar, plasma insulin, free fatty acid and triglyceride levels in normal subjects and in patients with type IV hyperlipoproteinemia and the effect of meal frequency. Schlierf G; Raetzer H Nutr Metab; 1972; 14(2):113-26. PubMed ID: 5051903 [No Abstract] [Full Text] [Related]
28. Diurnal blood sugar, insulin and free fatty acid fluctuations with nibbling and gorging in normal subjects and in patients with type IV hyperlipoproteinemia. Schlierf G; Raetzer H Isr J Med Sci; 1972 Jun; 8(6):830-1. PubMed ID: 5051809 [No Abstract] [Full Text] [Related]
29. Effect of glucagon and glucose load on glucose kinetics, plasma FFA, and insulin in dogs treated with methylprednisolone. Issekutz B; Borkow I Metabolism; 1973 Jan; 22(1):39-49. PubMed ID: 4681842 [No Abstract] [Full Text] [Related]
30. Operation of the glucose-fatty acid cycle after glycogenolysis induced by treatment with nicotinic acid. Benito M; Moreno FJ; Medina JM; Mayor F Arch Biochem Biophys; 1978 May; 188(1):21-5. PubMed ID: 209743 [No Abstract] [Full Text] [Related]
31. Effect of clofibrate on arginine-induced insulin and glucagon secretion. Eaton RP Metabolism; 1973 Jun; 22(6):763-7. PubMed ID: 4350845 [No Abstract] [Full Text] [Related]
32. Neonatal changes in the concentration of rat liver cyclic AMP and of serum glucose, free fatty acids, insulin, pancreatic, and total glucagon in man and in the rat. Blázquez E; Sugase T; Blázquez M; Foá PP J Lab Clin Med; 1974 Jun; 83(6):957-67. PubMed ID: 4370701 [No Abstract] [Full Text] [Related]
33. Modulation of the catabolic activity of glucagon by endogenous insulin secretion in obese man. Schade DS; Eaton PR Acta Diabetol Lat; 1977; 14(1-2):62-72. PubMed ID: 596102 [No Abstract] [Full Text] [Related]
34. Ingestion of thermally oxidized sunflower oil decreases postprandial lipemia mainly in younger individuals. Manning PJ; Sutherland WH; Manning AE; de Jong SA; Berry EA Nutr Res; 2013 Sep; 33(9):711-8. PubMed ID: 24034570 [TBL] [Abstract][Full Text] [Related]
35. The immediate effects of insulin and fructose on the metabolism of the perfused liver. Changes in lipoprotein secretion, fatty acid oxidation and esterification, lipogenesis and carbohydrate metabolism. Topping DL; Mayes PA Biochem J; 1972 Jan; 126(2):295-311. PubMed ID: 5071176 [TBL] [Abstract][Full Text] [Related]
36. Metabolic effects of nicotinic acid in acute insulin deficiency in the rat. Gross RC; Carlson LA Diabetes; 1968 Jun; 17(6):353-61. PubMed ID: 4968071 [No Abstract] [Full Text] [Related]
37. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. Havel RJ; Kane JP; Balasse EO; Segel N; Basso LV J Clin Invest; 1970 Nov; 49(11):2017-35. PubMed ID: 5475985 [TBL] [Abstract][Full Text] [Related]
38. Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics. Schade DS; Eaton RP Diabetes; 1975 May; 24(5):510-5. PubMed ID: 805077 [TBL] [Abstract][Full Text] [Related]
39. Suppression by hepatectomy of glucagon-induced hypertriglyceridemia in geese. De Oya M; Prigge WF; Grande F Proc Soc Exp Biol Med; 1971 Jan; 136(1):107-10. PubMed ID: 5540592 [No Abstract] [Full Text] [Related]
40. Effect of glucagon on lipids and glucose in normal and eviscerated rats and on isolated perfused rat livers. Gorman CK; Salter JM; Penhos JC Metabolism; 1967 Dec; 16(12):1140-57. PubMed ID: 6065181 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]